MannKind’s INHALE-1 Study: Pediatric Diabetes Breakthrough
MannKind completes enrollment for the INHALE-1 study, evaluating the efficacy of inhaled insulin Afrezza for pediatric diabetes treatment. Positive trial ...
- Latest
- Trending
MannKind completes enrollment for the INHALE-1 study, evaluating the efficacy of inhaled insulin Afrezza for pediatric diabetes treatment. Positive trial ...
Project Lifesaver's use of radio technology and tracking bracelets to locate missing persons with Alzheimer’s and autism is revolutionizing search ...
Project Lifesaver is a nonprofit utilizing radio technology to locate missing persons, particularly those with conditions like Alzheimer's or autism. ...
Phathom Pharmaceuticals' drug VOQUEZNA for Erosive GERD has been included in Express Scripts' formularies, providing relief to millions of patients. ...
A new molecular detection technology by BMRT is set to revolutionize medical, security, and military sectors with its ability to ...
Trinity Biotech announces a reverse ADS split to regain compliance and attract new investors. Analysts note strong returns but highlight ...
Clinical-stage biotech company Coya Therapeutics expands its IP portfolio with a license for a novel combination therapy using low dose ...
Biogen shares experience a significant 5% drop in premarket trading following disappointing earnings report, but CEO remains optimistic about the ...
Japanese stocks surged as the Nikkei reached a 34-year high due to strong corporate earnings and a surge in tech-related ...
Cocoa prices reaching record highs lead to more expensive chocolate as chocolate makers bear the cost hike, impacting the industry ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.